SCHEMBL8375118

SCHEMBL8375118

CCCN(C=C1CC=NC(N)=C1OC(=O)N(C)C)CCC

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375866 0.91 NCEH1 (0.33) NCEH1
SCHEMBL8375143 0.90 NCEH1 (0.32) NCEH1
SCHEMBL8375130 0.86 BCHE (0.33) NCEH1
SCHEMBL8374737 0.85 RAB9A (0.34) NCEH1
SCHEMBL8374755 0.81 NCEH1 (0.32) NCEH1
SCHEMBL8376714 0.78 MEN1 (0.38)
SCHEMBL8375879 0.77 ITGB1 (0.32)
SCHEMBL8378405 0.76 NCEH1 (0.34) NCEH1
SCHEMBL8376722 0.75
SCHEMBL8376582 0.75 ACHE (0.36) NCEH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US claimed
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed